Bristol Myers Squibb Integrates AI to Enhance Drug Development Processes
Bristol Myers Squibb is introducing Anthropic's Claude AI model to over 30,000 employees, seeking to reshape drug development and streamline operations.
More from this archive
Bristol Myers Squibb Expands AI Capabilities with Anthropic’s Claude
Bristol Myers Squibb is set to enhance its AI initiatives by deploying Anthropic’s Claude platform to over 30,000…
Tenable Partners with Anthropic to Enhance AI Offerings
Tenable shares surged 5% following a strategic partnership with Anthropic to integrate advanced AI capabilities into its cybersecurity…
Eurovision 2026 Sparks Controversy Amid Celebrity Headlines
Eurovision 2026 ignites drama with a tense winner announcement, while celebrity news takes center stage with controversies and…
Bristol-Myers Embraces Anthropic’s AI for Enhanced Operations
Bristol-Myers Squibb is leveraging Anthropic's Claude AI to improve its research, drug development, and operational efficiency, marking a…
The archive
sorted by latest
Europe’s AI Sovereignty Ambitions Face Infrastructure and Policy Challenges
GPUBeat Desk · 2 min
Intel Unveils LLM-Scaler-vLLM PV 1.4 with Enhanced Features
GPUBeat Desk · 1 min
Google DeepMind Unveils Gemini Omni for Advanced Video Generation
GPUBeat Desk · 2 min
Biren Technology Poised to Challenge Nvidia’s Dominance in AI GPUs
GPUBeat Desk · 3 min
AI-Powered Co-Scientist Revolutionizes Hypothesis Generation in Research
GPUBeat Desk · 3 min